GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Assets | ₹7,428 Cr | ₹8,424 Cr | ₹8,282 Cr | ₹7,360 Cr | ₹6,804 Cr |
What is the latest Total Current Assets ratio of GLENMARK PHARMACEUTICALS ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹7,428 Cr |
Mar2023 | ₹8,424 Cr |
Mar2022 | ₹8,282 Cr |
Mar2021 | ₹7,360 Cr |
Mar2020 | ₹6,804 Cr |
How is Total Current Assets of GLENMARK PHARMACEUTICALS Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹7,428 Cr | -11.82 | |
Mar2023 | ₹8,424 Cr | 1.71 | |
Mar2022 | ₹8,282 Cr | 12.54 | |
Mar2021 | ₹7,360 Cr | 8.17 | |
Mar2020 | ₹6,804 Cr | - |
Compare Total Current Assets of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹60,869.1 Cr | -0.8% | 25% | 50.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,466.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,298.0 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹127,538.0 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
CIPLA | ₹127,140.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,500.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -0.8% |
25% |
50.6% |
SENSEX | -1% |
-3.2% |
1.6% |
You may also like the below Video Courses